Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer CellsNicholas Don‐Doncow, Rebecka Hellsten|Journal of Biological Chemistry|2014Cited by 91
Galiellalactone Inhibits Stem Cell-Like ALDH-Positive Prostate Cancer CellsRebecka Hellsten, Anders Bjartell|PLoS ONE|2011Cited by 90
The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factorsRebecka Hellsten, Anders Bjartell|The Prostate|2019Cited by 70
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancerKristina Witt, Rebecka Hellsten|Cancer Immunology Immunotherapy|2021Cited by 33
STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell populationGiacomo Canesin, Rebecka Hellsten|Scientific Reports|2020Cited by 27